– Cystic Fibrosis Foundation provides $3 million in new funding to accelerate development of inhaled mRNA therapy for cystic fibrosis – – Research collaboration with Praxis Precision Medicines to develop LNP formulations for ASO delivery…
– The Cystic Fibrosis Foundation has agreed to invest up to $15 million in new funding to support the company’s gene correction development program with Intellia Therapeutics for the treatment of cystic fibrosis– November 18,…
According to filings with the U.S. Securities and Exchange Commission, Recode Therapeutics is raising $220,801,112.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Shehnaaz Suliman played a key role in…
Menlo Park, CA – According to filings with the U.S. Securities and Exchange Commission, ReCode Therapeutics is raising $80,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, David…